Sandbox Reserved 1627
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | {{Sandbox_Reserved_CH462_Biochemistry_II}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==''Homo sapiens'' Insulin Receptor Ectodomain== | ==''Homo sapiens'' Insulin Receptor Ectodomain== | ||
<StructureSection load='6SOF' size='350' frame='true' side='right' caption='Insulin Receptor Ectodomain 6SOF' scene=''> | <StructureSection load='6SOF' size='350' frame='true' side='right' caption='Insulin Receptor Ectodomain 6SOF' scene=''> | ||
| Line 15: | Line 14: | ||
The insulin receptor's function in regards to glucose homeostasis is to begin the signaling pathway that will eventually move glucose transporters to the cell surface which will allow glucose to passively defuse into the cell. The glucose receptor is inactive in the absence of insulin. When insulin does bind to the receptor, it undergoes a conformation change, activating it. Once activated, the intracellular Beta subunits autophosphorylate, and downstream signaling begins by the phosphorylation of the Insulin Receptor Substrate (IRS). | The insulin receptor's function in regards to glucose homeostasis is to begin the signaling pathway that will eventually move glucose transporters to the cell surface which will allow glucose to passively defuse into the cell. The glucose receptor is inactive in the absence of insulin. When insulin does bind to the receptor, it undergoes a conformation change, activating it. Once activated, the intracellular Beta subunits autophosphorylate, and downstream signaling begins by the phosphorylation of the Insulin Receptor Substrate (IRS). | ||
===Conformation Change=== | ===Conformation Change=== | ||
| - | The insulin receptor has two conformations, an active and inactive state. The inactive form predominates in low-levels of circulating insulin, whereas the active conformation is seen when insulin binds to any of the 4 receptor sites. The inactive conformation resembles an inverted V, and the active conformation resembles a T. Upon the binding of insulin to any of the four binding sites, the conformation change will begin, causing the Beta subunit's tyrosine kinase domains to move close together, allowing them to autophosphorylate. This autophosphorylation is what activates the insulin receptor and allows it to participate in further downstream signaling pathways. | + | The insulin receptor has two conformations, an active and inactive state. The inactive form predominates in low-levels of circulating insulin, whereas the active conformation is seen when insulin binds to any of the 4 receptor sites. The inactive conformation resembles an inverted V, and the active conformation resembles a T. Upon the binding of insulin to any of the four binding sites, the conformation change will begin, causing the Beta subunit's tyrosine kinase domains to move close together, allowing them to autophosphorylate. This autophosphorylation is what activates the insulin receptor and allows it to participate in further downstream signaling pathways. <ref> DOI 10.1038/s41467-018-06826-6</ref>. |
| Line 22: | Line 21: | ||
As mentioned in the Introduction, the insulin receptor is relevant to numerous biological functions of the body. In a healthy, normal-functioning human, each cell has many insulin receptors that reacts to insulin when blood glucose levels rise. Without properly functioning insulin receptors, medical intervention is necessary for survival. | As mentioned in the Introduction, the insulin receptor is relevant to numerous biological functions of the body. In a healthy, normal-functioning human, each cell has many insulin receptors that reacts to insulin when blood glucose levels rise. Without properly functioning insulin receptors, medical intervention is necessary for survival. | ||
=== Disease === | === Disease === | ||
| - | One of the most common diseases involving the insulin receptor is diabetes mellitus. There are two types of diabetes- which are referred to as type 1 and type 2 diabetes. Type 1 diabetes is classified as "insulin dependent" and is characterized by an inability for the body to produce insulin. This is most often the result of damage or insufficiency in the Islets of Langerhans in the pancreas. Type 2 diabetes is classified as "insulin independent" and is the result of the body producing insufficient amounts of insulin, or not responding to the insulin. This often occurs because of high blood-glucose levels. Both types of diabetes are often treated with insulin injections, and diet and lifestyle changes. | + | One of the most common diseases involving the insulin receptor is diabetes mellitus. There are two types of diabetes- which are referred to as type 1 and type 2 diabetes. Type 1 diabetes is classified as "insulin dependent" and is characterized by an inability for the body to produce insulin. This is most often the result of damage or insufficiency in the Islets of Langerhans in the pancreas. Type 2 diabetes is classified as "insulin independent" and is the result of the body producing insufficient amounts of insulin, or not responding to the insulin. This often occurs because of high blood-glucose levels. Both types of diabetes are often treated with insulin injections, and diet and lifestyle changes. <ref name="Wilcox"> PMID:16278749</ref>. <ref name= "Riddle"> PMID: 6351440</ref>. |
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1010832/ Treatment of Diabetes with Insulin] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1010832/ Treatment of Diabetes with Insulin] | ||
| - | <ref name="Wilcox"> PMID:16278749</ref>. | ||
| - | <ref name= "Riddle"> PMID: 6351440</ref>. | ||
| - | + | ||
| + | |||
</StructureSection> | </StructureSection> | ||
Revision as of 22:19, 23 March 2020
Homo sapiens Insulin Receptor Ectodomain
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ Weis F, Menting JG, Margetts MB, Chan SJ, Xu Y, Tennagels N, Wohlfart P, Langer T, Muller CW, Dreyer MK, Lawrence MC. The signalling conformation of the insulin receptor ectodomain. Nat Commun. 2018 Oct 24;9(1):4420. doi: 10.1038/s41467-018-06826-6. PMID:30356040 doi:http://dx.doi.org/10.1038/s41467-018-06826-6
- ↑ Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005 May;26(2):19-39. PMID:16278749
- ↑ Riddle MC. Treatment of diabetes with insulin. From art to science. West J Med. 1983 Jun;138(6):838-46. PMID:6351440
Student Contributors
- Harrison Smith
- Alyssa Ritter
